Alterations in metabolism are closely related to tumorigenesis and progression. An increasing number of metabolism-related molecules have become cancer markers or potential targets for cancer therapy. Cancer metabolic heterogeneity may stem from genetic diversity, complex metabolic pathways, and altered conditions of the tumour microenvironment. In recent years, tumour metabolic imaging techniques have been changing rapidly and many breakthroughs have been achieved. Numerous studies have shown that malignant tumours can be detected with high sensitivity and specificity by imaging glucose, amino acid, or lipid metabolic rates. However, broader studies on the in vivo metabolic dependence of human cancers are still needed to fully understand how metabolism influences and determines cancer onset, progression, and response to therapy. Non-invasive imaging techniques such as positron emission tomography (PET), magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), computed tomography (CT), photoacoustic imaging (PAI) and optical imaging provide valuable functional and anatomical information about tumor metabolism. These methods hold the potential for enhancing cancer diagnosis and treatment.
The aim of this research topic is to collect cancer metabolism studies performed in preclinical and clinical settings using non-invasive medical imaging methods. We also look forward to further developments in metabolic imaging methods to assess and quantify cancer metabolism in vivo. These efforts could improve tumour detection and diagnosis, ultimately enabling clinical oncologists to develop individualized treatment strategies based on tumour metabolism status.
The aim of this research topic is to collect cancer metabolism studies performed in preclinical and clinical settings using non-invasive medical imaging methods. We also look forward to further developments in metabolic imaging methods to assess and quantify cancer metabolism in vivo. These efforts could improve tumour detection and diagnosis, ultimately enabling clinical oncologists to develop individualized treatment strategies based on tumour metabolism status.
Keywords:
Metabolism, Tumour, Medical Imaging, Biomarker, Noninvasive
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Alterations in metabolism are closely related to tumorigenesis and progression. An increasing number of metabolism-related molecules have become cancer markers or potential targets for cancer therapy. Cancer metabolic heterogeneity may stem from genetic diversity, complex metabolic pathways, and altered conditions of the tumour microenvironment. In recent years, tumour metabolic imaging techniques have been changing rapidly and many breakthroughs have been achieved. Numerous studies have shown that malignant tumours can be detected with high sensitivity and specificity by imaging glucose, amino acid, or lipid metabolic rates. However, broader studies on the in vivo metabolic dependence of human cancers are still needed to fully understand how metabolism influences and determines cancer onset, progression, and response to therapy. Non-invasive imaging techniques such as positron emission tomography (PET), magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), computed tomography (CT), photoacoustic imaging (PAI) and optical imaging provide valuable functional and anatomical information about tumor metabolism. These methods hold the potential for enhancing cancer diagnosis and treatment.
The aim of this research topic is to collect cancer metabolism studies performed in preclinical and clinical settings using non-invasive medical imaging methods. We also look forward to further developments in metabolic imaging methods to assess and quantify cancer metabolism in vivo. These efforts could improve tumour detection and diagnosis, ultimately enabling clinical oncologists to develop individualized treatment strategies based on tumour metabolism status.
The aim of this research topic is to collect cancer metabolism studies performed in preclinical and clinical settings using non-invasive medical imaging methods. We also look forward to further developments in metabolic imaging methods to assess and quantify cancer metabolism in vivo. These efforts could improve tumour detection and diagnosis, ultimately enabling clinical oncologists to develop individualized treatment strategies based on tumour metabolism status.
Keywords:
Metabolism, Tumour, Medical Imaging, Biomarker, Noninvasive
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.